New Market Report Now Available: Iran Pharmaceuticals & Healthcare Report Q2 2011

Recently published research from Business Monitor International, "Iran Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research
March 21, 2011 - PRLog -- In BMI's Middle East and Africa Pharmaceutical Business Environment Ratings (BER) for Q211, Iran continued to slip down the rankings, as the absolute scores of other markets improved. The country now places 13th of the 19 markets surveyed in the Middle East and Africa (MEA) region. While some of its rewards are theoretically substantial, given its population of almost 75mn and widespread access to healthcare, the country remains a risky investment proposition, not least due to shortcomings within its intellectual property (IP) protection. Imports of medicines, however, will continue to grow as volume demand continues to develop, with more expensive treatments likely to have limited uptake within the more affluent sections of society and niche private healthcare facilities.

We calculate that per-capita spending on medicines in Iran reached US$32.4 in 2010, with the total market valued at IRR24,493bn (US$2.39bn), posting a local currency year-on-year (y-o-y) increase of 10.5%. However, inflation growth reached 14% in the same year, virtually negating the value increase in the market's size. In the 2010-2015 period, we forecast a local currency compound annual growth rate (CAGR) of 15.32%, which is comparable to the 2005-2010 period, but also a product of high inflation (expected to top 25% for most of the forecast period). Local currency depreciation will have a further negative impact on the market's attractiveness to foreign companies. We expect volume-based drivers to continue shaping the market, with negative pressures on prices continuing. Additionally, with purchasing power being lower compared with their regional peers, Iranian patients are likely to opt for generic medicines where possible.

In general terms, however, consumer awareness of the need to use pharmaceuticals more rationally and effectively must improve, with around 8% of annual hospital admissions thought to be a result of the misuse of medicines. In fact, according to statements made by Director of Pharmaceutical Affairs of Zanjan University of Medical Sciences in 2010, as many as 30% of patients treated for renal failure are suffering due to the incorrect or uncontrolled use of medicines, especially painkillers, which can have dramatic side-effects on the gastrointestinal system.

Additionally, the country's lacklustre growth prospects are weighing on the subdued outlook for the performance of the Iranian pharmaceutical market. We forecast the Iranian economy expanding by an average 2.0% y-o-y through FY2015/2016, weighed down in part by the effect of subsidy phase-outs and international sanctions over the country's political stance. We see private consumption moderating over the medium term, as subsidy cuts reduce consumers' purchasing power. Given that most pharmaceuticals incur an out-of-pocket fee, this consumer weakness will hinder the development of over-the-counter (OTC) medicines market in particular.

For more information or to purchase this report, go to:

Partial Table of Contents:

SWOT Analysis
- Table: Iran Pharmaceuticals And Healthcare Industry SWOT
- Iran Political SWOT
- Iran Economic SWOT
- Iran Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa - Pharmaceutical Business Environment Ratings Q211
- Rewards
- Risks
Iran - Market Summary
- Registration of Imports
- Generic Registration
- Intellectual Property (IP) Regime
- Intellectual Property Disputes
- Counterfeit Medicines
- Pricing and Reimbursement
- Recent Pricing and Reimbursement Developments
Industry Developments
- Epidemiology
- HIV/AIDS Situation
- Table: Iran HIV/AIDS Prevalence
- Healthcare Sector
- Healthcare Spending
- Primary Care
- Secondary Care
- Health Insurance
- International Healthcare Collaboration
- Traditional Herbal Remedies
- Research and Development
- Clinical Trials
- Biotechnology
- Medical Devices
Industry Forecast Scenario
- Overall Drug Market Forecast
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Healthcare Expenditure Indicators 2007-2015
- Table: Government Healthcare Expenditure Indicators 2007-2015
- Table: Private Healthcare Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic
- Table: Iran - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007-2015
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Export & Import Indicators 2007-2015
- Other Healthcare Data Forecasts
- Key Risks to BMI's Forecast Scenario
Competitive Landscape
- Pharmaceutical Industry
- Domestic Pharmaceutical Sector
- Table: Ian - Leading Drug Manufacturers in the Iranian Year to March 20 2009
- Pharmaceutical Wholesale
- Table: Iran - Leading Distributors in the Iranian Year to March 20, 2008

Full Table of Contents is available at:

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
Email:*** Email Verified
Tags:Medicines, Pharmaceutical, Iranian, Currency, Healthcare, Additionally, Patients, Purchasing, Subsidy
Industry:Health, Medical, Research
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Daily News
Weekly News

Like PRLog?
Click to Share